The recent Lancet Commission-International AIDS Society report: Advancing Global health and strengthening the HIV response in the Era of the Sustainable Development Goals; clearly highlights the fact that the world is NOT on track in ending the AIDS pandemic by 2030. Emphasis on massive and early diagnosis and placement on Combined Anti-Retroviral Therapy (cART) remain key cornerstones in reaching these goals.
Editorial
The recent Lancet Commission-International AIDS Society report:
Advancing Global health and Strengthening the HIV response in the Era of the Sustainable Development Goals; clearly highlights the fact that the world is NOT on track in ending the AIDS pandemic by 2030 [1] . Many persons in developing countries still do not know their HIV status [1, 2] . Emphasis on massive and early diagnosis and placement on Combined Anti-Retroviral Therapy (cART) remain key cornerstones in reaching these goals. The test and treat approach has heightened hopes in encouraging self-testing, as a possible tool, which is almost stigma free, and allows hard to reach groups (e.g Men Who Have Sex with men; MSM, Intra venous Drug Users; IDUs) to know their HIV serological status [3] . It has been argued elsewhere that this approach must only complement clinic based testing, as linkage to care, sustainability concerns, clear selftesting national policies, and quality assurance challenges still constitute understudied and underexplored barriers, especially in the most infected and affected countries of the world [4] [5] [6] . In low and middle-income countries (LMICs), stigma, discrimination and access to key populations (MSM, transgender persons, sex workers, IDUs, and prisoners) might constitute a key impediment in preventing new infections. For instance, key populations accounted for over 47% of new infections in 2017 [7] . The risk of acquiring HIV is 27 times higher among men who have sex with men; 23 times higher among people who inject drugs; 13 times higher for female sex workers; 12 times higher for transgender women [8] . Key populations stand to constitute a breeding ground for a new cycle of new infections in the shadows. However, the world has been too ambitious in forgetting so early that HIV related stigma is real, serious and remains a major issue of concern [7] [8] [9] [10] . This parameter must be provided the real attention it deserves.
Many countries are still unable to maintain a reasonable and effective supply chains for cART [11] . There is indisputable evidence that placement of People Living with HIV (PLHIV) on cART is key in breaking the transmission chain [12, 13] There is lack of quality data, especially in LMICs, which makes monitoring of the pandemic very problematic [17, 18] . Funders and governments must specifically include quality data collection and information schemes in their health system strengthening agendas of countries as a whole, and for HIV in particular. Dependence on foreign aid and imported management models will not be helpful in 
